NVDA
NVIDIA Corporation
NVDA has the edge over PEGA overall, supported by stronger fundamentals and stronger modeled upside.
PEGA
Pegasystems Inc.
PEGA trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PEGA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
PEGA's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over PEGA in the historical PE scenario, which offers more potential upside but is not a forecast.
PEGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $32.04 | — |
| Cheap | 26x | $30.01 | -6.3% |
| Current | 28x | $32.04 | — |
| Fair | 46x | $53.25 | +66% |
| Expensive | 75x | $86.65 | +170% |
Historical ranges are pointers, not guarantees.
PEGA's PE is in its cheap range at 28x. On analysts' estimates for next year's earnings, today's price would be 14x.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PEGA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect PEGA's earnings, revenue and profitability to hold roughly steady.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PEGA on earnings, with more consistent year-over-year improvement.
PEGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.34 | +103% |
| Q3 2026 | $1.15 | -25% |
| Q2 2026 | $1.31 | +7.4% |
| Q1 2026 | $1.40 | +30% |
| Q4 2025 | $1.67 | +198% |
| Q3 2025 | $1.54 | +123% |
| Q2 2025 | $1.22 | +67% |
| Q1 2025 | $1.08 | +157% |
| Q4 2024 | $0.56 | +56% |
PEGA earned $1.15 per share over the past year, down 25% from the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PEGA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PEGA on profitability, with a higher operating margin.
PEGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $393.4M | +3.1% |
| Q2 2026 | $420.7M | +9.4% |
| Q1 2026 | $430M | -9.6% |
| Q4 2025 | $504.3M | +2.7% |
| Q3 2025 | $381.4M | +17% |
| Q2 2025 | $384.5M | +9.5% |
| Q1 2025 | $475.6M | +44% |
| Q4 2024 | $490.8M | +3.5% |
PEGA's revenue has held roughly level: $393M last quarter, up 3.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | 0 points |
| Q2 2026 | 4% | -0.5 points |
| Q1 2026 | 8.6% | -18 points |
| Q4 2025 | 21% | -8.4 points |
| Q3 2025 | 3.8% | +7.4 points |
| Q2 2025 | 4.5% | +0.8 points |
| Q1 2025 | 27% | +33 points |
| Q4 2024 | 29% | -3.6 points |
PEGA's operating margin was 3.8% last quarter, about level with the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PEGA on cash flow, with more consistent year-over-year improvement.
PEGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | -97% |
| Q2 2026 | $81.7M | -2.9% |
| Q1 2026 | $206.5M | +2.1% |
| Q4 2025 | $152.4M | +65% |
| Q3 2025 | $51.8M | +89% |
| Q2 2025 | $84.1M | +117% |
| Q1 2025 | $202.3M | +13% |
| Q4 2024 | $92.4M | +19% |
PEGA generated $442M in free cash flow over the past year, up 2.7% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PEGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.5x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | 0.9x | Very low |
PEGA has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PEGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 32.6 | Neutral |
PEGA's weekly RSI is 43 (neutral) and its Stochastic is 33 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over PEGA on valuation relative to its sector.
PEGA PE vs Technology Sector
| Metric | PEGA | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | Same PE |
| PE % | 22 | 35 | 13 pts below |
PEGA is trading at 28x earnings, in line with the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over PEGA on trend strength, trading above more of its moving averages.
PEGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.1 | 6% below |
| 20 week MA | $33.4 | 4.1% below |
| 50 week MA | $39.7 | 19% below |
| 100 week MA | $44.7 | 28% below |
| 200 week MA | $36.5 | 12% below |
PEGA is in a downtrend: it's below all five of its weekly moving averages, and 12% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over PEGA on returns for 2026, with the stronger performance.
PEGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.7 | $69.3 | +75% |
| 2021 | $69.3 | $55.2 | -20% |
| 2022 | $55.2 | $17.1 | -69% |
| 2023 | $17.1 | $24.4 | +43% |
| 2024 | $24.4 | $47.2 | +93% |
| 2025 | $47.2 | $62.4 | +32% |
| 2026 YTD | $62.4 | $32.0 | -49% |
PEGA is down 49% so far in 2026, after finishing higher in four of the previous six years.